West Pharmaceutical Services Stock Filter Stocks by Fundamentals
| WST Stock | USD 333.22 0.21 0.06% |
West Pharmaceutical Services fundamentals help investors to digest information that contributes to West Pharmaceutical's financial success or failures. It also enables traders to predict the movement of West Stock. The fundamental analysis module provides a way to measure West Pharmaceutical's intrinsic value by examining its available economic and financial indicators, including the cash flow records, the balance sheet account changes, the income statement patterns, and various microeconomic indicators and financial ratios related to West Pharmaceutical stock.
West | Shares Owned by Institutions |
West Pharmaceutical ESG Sustainability
Some studies have found that companies with high sustainability scores are getting higher valuations than competitors with lower social-engagement activities. While most ESG disclosures are voluntary and do not directly affect the long term financial condition, West Pharmaceutical's sustainability indicators can be used to identify proper investment strategies using environmental, social, and governance scores that are crucial to West Pharmaceutical's managers, analysts, and investors.Environmental | Governance | Social |
West Pharmaceutical Institutional Holders
Institutional Holdings refers to the ownership stake in West Pharmaceutical that is held by large financial organizations, pension funds or endowments. Institutions may purchase large blocks of West Pharmaceutical's outstanding shares and can exert considerable influence upon its management. Institutional holders may also work to push the share price higher once they own the stock. Extensive social media coverage, TV shows, articles in high-profile magazines, and presentations at investor conferences help move the stock higher, increasing West Pharmaceutical's value.| Shares | Proshare Advisors Llc | 2024-09-30 | 1.1 M | Durable Capital Partners Lp | 2024-09-30 | 1.1 M | Morgan Stanley - Brokerage Accounts | 2024-09-30 | 971.5 K | Jpmorgan Chase & Co | 2024-09-30 | 968.4 K | Norges Bank | 2024-06-30 | 866.4 K | T. Rowe Price Investment Management,inc. | 2024-09-30 | 839.3 K | Findlay Park Partners Llp | 2024-09-30 | 827.7 K | Amvescap Plc. | 2024-09-30 | 747.4 K | Ubs Asset Mgmt Americas Inc | 2024-09-30 | 683.4 K | Vanguard Group Inc | 2024-09-30 | 9 M | Blackrock Inc | 2024-06-30 | 7.6 M |
West Fundamentals
| Return On Equity | 0.18 | ||||
| Return On Asset | 0.1 | ||||
| Profit Margin | 0.17 % | ||||
| Operating Margin | 0.22 % | ||||
| Current Valuation | 23.95 B | ||||
| Shares Outstanding | 72.42 M | ||||
| Shares Owned By Insiders | 0.58 % | ||||
| Shares Owned By Institutions | 96.62 % | ||||
| Number Of Shares Shorted | 1.16 M | ||||
| Price To Earning | 40.71 X | ||||
| Price To Book | 8.77 X | ||||
| Price To Sales | 8.39 X | ||||
| Revenue | 2.95 B | ||||
| Gross Profit | 1.14 B | ||||
| EBITDA | 844.1 M | ||||
| Net Income | 593.4 M | ||||
| Cash And Equivalents | 894.3 M | ||||
| Cash Per Share | 9.85 X | ||||
| Total Debt | 309 M | ||||
| Debt To Equity | 0.12 % | ||||
| Current Ratio | 3.80 X | ||||
| Book Value Per Share | 37.96 X | ||||
| Cash Flow From Operations | 776.5 M | ||||
| Short Ratio | 1.86 X | ||||
| Earnings Per Share | 6.73 X | ||||
| Price To Earnings To Growth | 6.22 X | ||||
| Target Price | 378.17 | ||||
| Number Of Employees | 10.6 K | ||||
| Beta | 1.0 | ||||
| Market Capitalization | 24.13 B | ||||
| Total Asset | 3.83 B | ||||
| Retained Earnings | 3.52 B | ||||
| Working Capital | 1.26 B | ||||
| Current Asset | 673.7 M | ||||
| Current Liabilities | 314.3 M | ||||
| Annual Yield | 0 % | ||||
| Five Year Return | 0.36 % | ||||
| Net Asset | 3.83 B | ||||
| Last Dividend Paid | 0.8 |
About West Pharmaceutical Fundamental Analysis
The Macroaxis Fundamental Analysis modules help investors analyze West Pharmaceutical Services's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of West Pharmaceutical using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of West Pharmaceutical Services based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Please read more on our fundamental analysis page.
Thematic Opportunities
Explore Investment Opportunities
Additional Tools for West Stock Analysis
When running West Pharmaceutical's price analysis, check to measure West Pharmaceutical's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy West Pharmaceutical is operating at the current time. Most of West Pharmaceutical's value examination focuses on studying past and present price action to predict the probability of West Pharmaceutical's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move West Pharmaceutical's price. Additionally, you may evaluate how the addition of West Pharmaceutical to your portfolios can decrease your overall portfolio volatility.